Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 2 |
2009 | 3 |
2011 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Biomarkers of response and resistance to antiangiogenic therapy.
Nat Rev Clin Oncol. 2009 Jun;6(6):327-38. doi: 10.1038/nrclinonc.2009.63.
Nat Rev Clin Oncol. 2009.
PMID: 19483739
Free PMC article.
Review.
Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma.
Dietrich J, Wang D, Batchelor TT.
Dietrich J, et al.
Expert Opin Investig Drugs. 2009 Oct;18(10):1549-57. doi: 10.1517/13543780903183528.
Expert Opin Investig Drugs. 2009.
PMID: 19671039
Free PMC article.
Review.
Item in Clipboard
VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects.
Duda DG, Batchelor TT, Willett CG, Jain RK.
Duda DG, et al.
Trends Mol Med. 2007 Jun;13(6):223-30. doi: 10.1016/j.molmed.2007.04.001. Epub 2007 Apr 25.
Trends Mol Med. 2007.
PMID: 17462954
Free PMC article.
Item in Clipboard
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.
di Tomaso E, Snuderl M, Kamoun WS, Duda DG, Auluck PK, Fazlollahi L, Andronesi OC, Frosch MP, Wen PY, Plotkin SR, Hedley-Whyte ET, Sorensen AG, Batchelor TT, Jain RK.
di Tomaso E, et al.
Cancer Res. 2011 Jan 1;71(1):19-28. doi: 10.1158/0008-5472.CAN-10-2602.
Cancer Res. 2011.
PMID: 21199795
Free PMC article.
Item in Clipboard
Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma.
Kim H, Catana C, Ratai EM, Andronesi OC, Jennings DL, Batchelor TT, Jain RK, Sorensen AG.
Kim H, et al.
Cancer Res. 2011 Jun 1;71(11):3745-52. doi: 10.1158/0008-5472.CAN-10-2991. Epub 2011 Apr 20.
Cancer Res. 2011.
PMID: 21507932
Free PMC article.
Clinical Trial.
Item in Clipboard
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK.
Batchelor TT, et al.
Cancer Cell. 2007 Jan;11(1):83-95. doi: 10.1016/j.ccr.2006.11.021.
Cancer Cell. 2007.
PMID: 17222792
Free PMC article.
Clinical Trial.
Item in Clipboard
A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.
Sorensen AG, Batchelor TT, Zhang WT, Chen PJ, Yeo P, Wang M, Jennings D, Wen PY, Lahdenranta J, Ancukiewicz M, di Tomaso E, Duda DG, Jain RK.
Sorensen AG, et al.
Cancer Res. 2009 Jul 1;69(13):5296-300. doi: 10.1158/0008-5472.CAN-09-0814. Epub 2009 Jun 23.
Cancer Res. 2009.
PMID: 19549889
Free PMC article.
Item in Clipboard
Cite
Cite